The epiMelanoma test enables plasma-based detection of melanoma and prediction of immunotherapy response.

However, the difference between both normal melanocytes and skin, as well as between tumor samples and skin, was not only highly significant (adjusted p -values < 0.0001) but also substantially larger in magnitude, as shown in Fig. 2 E.

also in 132,142 other papers